Page 1 of Clinical Trials for Glioblastoma multiforme, 722 Total Matches
- 1TerminatedLast Updated: December 29, 2009Condition(s): Glioblastoma Multiforme
- 2CompletedLast Updated: December 6, 2011Condition(s): Anaplastic Glioma of Brain; Glioblastoma Multiforme; Brain Cancer
- 3RecruitingLast Updated: August 12, 2011Condition(s): Glioblastoma Multiforme; GBM; Brain Cancer
- 4RecruitingLast Updated: January 30, 2012Condition(s): Glioblastoma Multiforme
- 5Active, not recruitingLast Updated: June 2, 2011Condition(s): Glioblastoma Multiforme
- 6WithdrawnLast Updated: January 6, 2009Condition(s): Glioblastoma Multiforme
- 7Not yet recruitingLast Updated: November 24, 2008Condition(s): Glioblastoma Multiforme
- 8RecruitingLast Updated: September 12, 2011Condition(s): Glioblastoma Multiforme; Anaplastic Glioma
- 9TerminatedLast Updated: September 20, 2011Condition(s): Glioblastoma Multiforme
- 10CompletedLast Updated: May 2, 2011Condition(s): Glioblastoma Multiforme
- 11RecruitingLast Updated: June 23, 2011Condition(s): Recurrent Glioblastoma Multiforme; Recurrent Gliosarcoma
- 12TerminatedLast Updated: September 17, 2009Condition(s): Glioblastoma Multiforme
- 13Active, not recruitingLast Updated: August 27, 2010Condition(s): Glioblastoma Multiforme
- 14RecruitingParvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.Last Updated: September 27, 2011Condition(s): Glioblastoma Multiforme
- 15RecruitingLast Updated: February 24, 2011Condition(s): Brain and Central Nervous System Tumors
- 16CompletedLast Updated: February 2, 2012Condition(s): Glioblastoma Multiforme
- 17RecruitingPI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma MultiformLast Updated: July 12, 2011Condition(s): Glioblastoma; Cancer of Brain and Nervous System; Glioblastoma Multiforme
- 18RecruitingLast Updated: May 29, 2007Condition(s): Glioblastoma Multiforme
- 19Not yet recruitingLast Updated: November 21, 2011Condition(s): Glioblastoma Multiforme
- 20Active, not recruitingPhase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma MultiformeLast Updated: January 16, 2012Condition(s): Glioblastoma Multiforme
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Glioblastoma+multiforme
